Familial Parkinson's disease: clinical and genetic analysis of four Basque families
- PMID: 15732106
- DOI: 10.1002/ana.20391
Familial Parkinson's disease: clinical and genetic analysis of four Basque families
Abstract
During the last few years several loci have been linked to Mendelian forms of Parkinson's disease (PD). To date, 5 causative genes of 10 identified loci are known, and they have provided enormous insight into the molecular pathways involved in this common neurodegenerative disorder. One of the recently identified loci, PARK8, causes autosomal dominant PD with, apparently, various degrees of abnormal deposition of alpha-synuclein or tau in the neuronal cells in the pedigrees currently reported. We genetically characterized four Basque families and found evidence for linkage of autosomal dominant PD to the PARK8 locus, with a maximum 2-point logarithm of odds score of 3.21 (theta = 0.00) for marker D12S345. The clinical features of these families are those of typical PD, including good response to levodopa therapy, rigidity, and akinesia, and a mean age of 55 years at disease onset.
Similar articles
-
Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.Brain. 2005 Dec;128(Pt 12):2786-96. doi: 10.1093/brain/awh667. Epub 2005 Nov 4. Brain. 2005. PMID: 16272164
-
Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.J Neural Transm Suppl. 2006;(70):221-9. doi: 10.1007/978-3-211-45295-0_34. J Neural Transm Suppl. 2006. PMID: 17017533 Review.
-
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.Neuron. 2004 Nov 18;44(4):595-600. doi: 10.1016/j.neuron.2004.10.023. Neuron. 2004. PMID: 15541308
-
LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.Neurology. 2007 Oct 30;69(18):1737-44. doi: 10.1212/01.wnl.0000278115.50741.4e. Epub 2007 Sep 5. Neurology. 2007. PMID: 17804834
-
PARK8 LRRK2 parkinsonism.Curr Neurol Neurosci Rep. 2006 Jul;6(4):287-94. doi: 10.1007/s11910-006-0020-0. Curr Neurol Neurosci Rep. 2006. PMID: 16822348 Review.
Cited by
-
LRRK2 Antisense Oligonucleotides Ameliorate α-Synuclein Inclusion Formation in a Parkinson's Disease Mouse Model.Mol Ther Nucleic Acids. 2017 Sep 15;8:508-519. doi: 10.1016/j.omtn.2017.08.002. Epub 2017 Aug 10. Mol Ther Nucleic Acids. 2017. PMID: 28918051 Free PMC article.
-
The use of next-generation sequencing in movement disorders.Front Genet. 2012 May 14;3:75. doi: 10.3389/fgene.2012.00075. eCollection 2012. Front Genet. 2012. PMID: 22593763 Free PMC article.
-
From Synaptic Dysfunction to Neuroprotective Strategies in Genetic Parkinson's Disease: Lessons From LRRK2.Front Cell Neurosci. 2020 Jul 28;14:158. doi: 10.3389/fncel.2020.00158. eCollection 2020. Front Cell Neurosci. 2020. PMID: 32848606 Free PMC article. Review.
-
Genetics of parkinsonism.Curr Neurol Neurosci Rep. 2005 Sep;5(5):397-404. doi: 10.1007/s11910-005-0064-6. Curr Neurol Neurosci Rep. 2005. PMID: 16131423 Review.
-
Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.Neurobiol Aging. 2014 Nov;35(11):2656.e17-2656.e23. doi: 10.1016/j.neurobiolaging.2014.05.025. Epub 2014 Jun 2. Neurobiol Aging. 2014. PMID: 24973808 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical